Cardurion Raises $260m To Advance First-In-Class Cardiovascular Drugs

Bain Previously Provided Up To $300m

3D illustration of a human heart presented in geometric shapes consisting of white lines scattered around its periphery
Cardurion's series B also will fund drug discovery and business development • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Financing

More from Business